This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Methyl dopa

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Methyl dopa is a centrally-acting antihypertensive drug that is gradually declining in usage. It inhibits decarboxylation of dopa to dopamine. Therapy is associated with reduced concentrations of dopamine, 5 - hydroxytryptamine and noradrenaline in peripheral tissues and the CNS. This drug is associated with a reduction in renin levels.

Indications for the use of methyl dopa include:

  • hypertension, in conjunction with a diuretic
  • hypertensive crisis when an immediate effect is not necessary

Cautions/Contraindications:

  • history of depression
  • active liver disease
  • porphyria
  • phaeochromocytoma
  • increases the CNS toxicity of lithium

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.